Loading insider details...
Beta
Latest Form 4 (Jul 9, 2026): Other (see footnotes) of 1,453 TNXP shares, $15.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 9, 2026 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Other (see footnotes) | 1,453 | $15.9K |
| Feb 26, 2026 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 39,012 | n/a |
| Feb 27, 2025 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Other (see footnotes) | 0 | n/a |
| Feb 29, 2024 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 282,000 | n/a |
| Feb 24, 2023 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 200,000 | n/a |
| Feb 17, 2022 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 900,000 | n/a |
| Feb 25, 2021 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 540,000 | n/a |
| May 6, 2020 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 360,000 | n/a |
| Feb 27, 2020 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 24,000 | n/a |